Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 531

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 531
---
arrants inclusive of the underwriters’ over -allotmentoption) in accordance with the guidance contained in ASC 815 -40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re -measurementat each balance sheet date. With each such re -measurement, the warrant liabilities will be adjusted to fair value, with the change in fair value recognized in the Company’s consolidated statements of operations (See Note 8). In determining the fair value of the Private Placement Warrants and the Representative’s Warrants, assumptions related to expected share -pricevolatility, expected life and risk -freeinterest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. Net (Loss) Income Per Common Stock The Company has two categories of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata between the two categories of shares. The 17,404,250potential shares of common stock for outstanding warrants to purchase the Company’s shares were excluded from diluted earnings per share for the years ended December31, 2024 and 2023 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net (loss) income per share of common F-15

NORTHVIEW ACQUISITION CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Note 2 — Summary of Significant Accounting Policies (cont.)

stock is the same as basic net (loss) income per share of common stock for the periods presented.

|                                                |     | For the Year Ended December 31, 2024 |            |   |     |        |            |   |     | For the Year Ended December 31, 2023 |           |     |        |           |
|:-----------------------------------------------|:----|:-------------------------------------|-----------:|:--|:----|:-------|-----------:|:--|:----|:-------------------------------------|----------:|:----|:-------|----------:|
|                                                |     | Common stock                         
 subject to                           
 possible                             
 redemption                           |            |   |     | Common 
 stock  |            |   |     | Common stock                         
 subject to                           
 possible                             
 redemption                           |           |     | Common